Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 11thDecember 2014
Summary The industry analysis specialist, has released its new report, “Gonorrhea Therapeutics Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Gonorrhea Therapeutics market. The report identifies the key trends shaping and driving the global Gonorrhea Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Gonorrhea Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-gonorrhea-therapeutics-pipeline-assessment-and-market-forecasts135201 Scope The report provides information on the key drivers and challenges of the Gonorrhea Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Gonorrhea Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Gonorrhea Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Gonorrhea Therapeutics market. - Analysis of key recent licensing and partnership agreements in Gonorrhea Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Gonorrhea Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Gonorrhea Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Gonorrhea Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Gonorrhea - Introduction 2.1 Overview 2.2 Epidemiology 2.3 Etiology 2.4 Pathophysiology 2.5 Signs and Symptoms 2.5.1 Signs and Symptoms in Females 2.5.2 Signs and Symptoms in Males 2.6 Commonly Used Diagnostic Tests 2.7 Treatment and Management Options for Gonorrhea 2.8 Prognosis 2.9 GlobalData Pipeline Report Guidance 3 Gonorrhea Therapeutics - Market Characterization 3.1 Gonorrhea Therapeutics Market Size (2006-2011) - Global 3.2 Gonorrhea Therapeutics Market Forecast (2011-2019) - Global 3.3 Gonorrhea Therapeutics Market Size (2006-2011) - The US 3.4 Gonorrhea Therapeutics Market Forecast (2011-2019) - The US 3.5 Gonorrhea Therapeutics Market Size (2006-2011) - France Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
3.6 Gonorrhea Therapeutics Market Forecast (2011-2019) - France 3.7 Gonorrhea Therapeutics Market Size (2006-2011) - Germany 3.8 Gonorrhea Therapeutics Market Forecast (2011-2019) - Germany 3.9 Gonorrhea Therapeutics Market Size (2006-2011) - Italy 3.10 Gonorrhea Therapeutics Market Forecast (2011-2019) - Italy 3.11 Gonorrhea Therapeutics Market Size (2006-2011) - Spain 3.12 Gonorrhea Therapeutics Market Forecast (2011-2019) - Spain 3.13 Gonorrhea Therapeutics Market Size (2006-2011) - The UK 3.14 Gonorrhea Therapeutics Market Forecast (2011-2019) - The UK 3.15 Gonorrhea Therapeutics Market Size (2006-2011) - Japan 3.16 Gonorrhea Therapeutics Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for the Gonorrhea Market 3.17.1 Gonorrhea Therapeutics Market Drivers 3.17.2 Gonorrhea Therapeutics Market Barriers 3.18 Opportunity and Unmet Need 4 Gonorrhea Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profile Marketed Products in the Gonorrhea Therapeutics Market 4.3.1 Cephalosporins 4.3.2 Cefixime 4.3.3 Ceftriaxone 4.3.4 Doxycycline 4.3.5 Azithromycin 4.4 Key Takeaway 5 Gonorrhea Therapeutics - Pipeline Assessment 6 Gonorrhea Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (US, EU-5 and Japan) 6.2 Clinical Trials by Phase of Clinical Development 6.3 Clinical Trials by Trial Status 6.4 Clinical Trial by Prominent Sponsors 6.5 Clinical Trials by Overall Sponsors 6.6 Company Participating in Gonorrhea Therapeutics Clinical Trials 7 Gonorrhea Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 Gonorrhea Therapeutics - Licensing & Partnership Deals 9 Gonorrhea Therapeutics - Appendix 9.1 Market Definitions Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
9.2 Acronyms 9.3 Research Methodology 9.3.1 Coverage 9.3.2 Secondary Research 9.3.3 Forecasting 9.3.4 Primary Research 9.3.5 Expert Panel Validation 9.4 Contact Us 9.5 Disclaimer 9.6 Bibliography
List Of Tables Table 1: Incidence of Gonorrhea Table 2: Treatments Regimens for Gonococcal Infection and Associated Conditions Table 3: Treatments Regimens for Pelvic Inflammatory Disease (PID) Table 4: Gonorrhea Therapeutics Market, Global, Revenue ($m), 2006–2011 Table 5: Gonorrhea Therapeutics, Market, Global, Forecast ($m), 2011–2019 Table 6: Gonorrhea Therapeutics Market, The US, Revenue ($m), 2006–2011 Table 7: Gonorrhea Therapeutics Market, The US, Forecasts ($m), 2011–2019 Table 8: Gonorrhea Therapeutics Market, France, Revenue ($’000), 2006–2011 Table 9: Gonorrhea Therapeutics Market, France, Forecasts ($’000), 2011–2019 Table 10: Gonorrhea Therapeutics Market, Germany, Revenue ($’000), 2006–2011 Table 11: Gonorrhea Therapeutics Market, Germany, Forecasts ($’000), 2011–2019 Table 12: Gonorrhea Therapeutics Market, Italy, Revenue ($’000), 2006–2011 Table 13: Gonorrhea Therapeutics Market, Italy, Forecasts ($’000), 2011–2019 Table 14: Gonorrhea Therapeutics Market, Spain, Revenue ($’000), 2006–2011 Table 15: Gonorrhea Therapeutics Market, Spain, Forecasts ($’000), 2011–2019 Table 16: Gonorrhea Therapeutics Market, The UK, Revenue ($’000), 2006–2011 Table 17: Gonorrhea Therapeutics Market, The UK, Forecasts ($’000), 2011–2019 Table 18: Gonorrhea Therapeutics Market, Japan, Revenue ($’000), 2006–2011 Table 19: Gonorrhea Therapeutics Market, Japan, Forecasts ($’000), 2011–2019 Table 20: Gonorrhea Therapeutics – Clinical Trials by Country, 2011 Table 21: Gonorrhea Therapeutics, Major Markets – Clinical Trials by Phase, 2011 Table 22: Gonorrhea Therapeutics, Major Markets, Clinical Trials by Development Status, 2011 Table 23: Gonorrhea Therapeutics – Prominent Sponsors, 2011 Table 24: Gonorrhea Therapeutics – Overall Sponsors, 2011 Table 25: Gonorrhea Therapeutics, Global, Deals Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
List Of Figures Figure 1: Gonorrhea Therapeutics Market, Global, Revenue ($m), 2006–2011 Figure 2: Gonorrhea Therapeutics Market, Global, Forecast ($m), 2011–2019 Figure 3: Gonorrhea Therapeutics Market, The US, Revenue ($m), 2006–2011 Figure 4: Gonorrhea Therapeutics Market, The US, Forecast ($m), 2011–2019 Figure 5: Gonorrhea Therapeutics Market, France, Revenue ($’000), 2006–2011 Figure 6: Gonorrhea Therapeutics Market, France, Forecast ($’000), 2011–2019 Figure 7: Gonorrhea Therapeutics Market, Germany, Revenue ($’000), 2006–2011 Figure 8: Gonorrhea Therapeutics Market, Germany, Forecast ($’000), 2011–2019 Figure 9: Gonorrhea Therapeutics Market, Italy, Revenue ($’000), 2006–2011 Figure 10: Gonorrhea Therapeutics Market, Italy, Forecast ($’000), 2011–2019 Figure 11: Gonorrhea Therapeutics Market, Spain, Revenue ($’000), 2006–2011 Figure 12: Gonorrhea Therapeutics Market, Spain, Forecast ($’000), 2011–2019 Figure 13: Gonorrhea Therapeutics Market, The UK, Revenue ($’000), 2006–2011 Figure 14: Gonorrhea Therapeutics Market, The UK, Forecast ($’000), 2011–2019 Figure 15: Gonorrhea Therapeutics Market, Japan, Revenue ($’000), 2006–2011 Figure 16: Gonorrhea Therapeutics Market, Japan, Forecast ($’000), 2011–2019 Figure 17: Opportunity and Unmet Need in the Gonorrhea Therapeutics Market Figure 18: Strategic Competitor Assessment, 2011 Figure 19: Gonorrhea Therapeutics, Major Markets – Clinical Trials by Phase, 2011 Figure 20: Gonorrhea Therapeutics, Major Markets, Clinical Trials by Development Status, 2011 Figure 21: Gonorrhea Therapeutics, Major Markets, Overall Sponsors, 2011 Figure 22: Gonorrhea Therapeutics, Major Markets, Prominent Sponsors, 2011 Figure 23: Gonorrhea Therapeutics Market, Drivers and Restraints 2011 Figure 24: Implications for Future Market Competition in the Gonorrhea Therapeutics Market, 2011 Figure 25: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Related Reports: Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019 Toxoplasmosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Skin and Skin Structure Infections (SSSI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019 Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-gonorrheatherapeutics-pipeline-assessment-and-market-forecasts-135201
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/